Return to homepagePandemic Pact

Classifying a COVID-19 epigenetic signature for precision diagnostic assay

  • Funded by North Carolina Biotechnology Center
  • Total publications:0 publications

Grant number: unknown

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    N/A

  • Known Financial Commitments (USD)

    $20,000

  • Funder

    North Carolina Biotechnology Center

  • Principal Investigator

    Xiling Shen

  • Research Location

    United States of America

  • Lead Research Institution

    Duke University

  • Research Priority Alignment

    N/A

  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Diagnostics

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    N/A

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

Researchers will build a diagnostic assay to accurately diagnose COVID-19 and predict the severity of patient response to the disease.